Leukemia Research Reports最新文献

筛选
英文 中文
Myeloid/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations 髓系/淋巴肿瘤伴ZMYM2: FGFR1重排:复杂的三代表型和克隆进化与相关的基因组改变
Leukemia Research Reports Pub Date : 2023-01-01 DOI: 10.1016/j.lrr.2023.100370
Dong Chen , Guang Liu , Michael R. Lewis , Xia Li , Matthew Ulrickson , Rajneesh Nath , Weina Chen
{"title":"Myeloid/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations","authors":"Dong Chen ,&nbsp;Guang Liu ,&nbsp;Michael R. Lewis ,&nbsp;Xia Li ,&nbsp;Matthew Ulrickson ,&nbsp;Rajneesh Nath ,&nbsp;Weina Chen","doi":"10.1016/j.lrr.2023.100370","DOIUrl":"https://doi.org/10.1016/j.lrr.2023.100370","url":null,"abstract":"<div><p>We report a case of myeloid/lymphoid neoplasm with <em>ZMYM2::FGFR1</em> rearrangement (MLN<em><sup>ZMYM2::FGFR1</sup></em>) exhibiting a complex disease evolution. This neoplasm initially presented as T-lymphoblastic lymphoma (T-LBL) in lymph node and myeloproliferative neoplasm (MPN) with eosinophilia in bone marrow, then transitioned to systemic mastocytosis (SM) likely accompanied by additional <em>JAK3</em> and other mutations and finally transformed to acute myeloid leukemia (AML) accompanied by additional/secondary genetic abnormality (gain of chromosome 21, der(13)t(8;13), and <em>RUNX1</em> mutation). To our knowledge, this is the first case of MLN<em><sup>ZMYM2::FGFR1</sup></em> with a complex trilineage/phenotypic [T-cell (T-LBL), mast cell (SM), and myeloid (MPN and AML)] lineage evolution.</p></div>","PeriodicalId":38435,"journal":{"name":"Leukemia Research Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49856568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Location, location, location: A mini-review of CEBPA variants in patients with acute myeloid leukemia 位置,位置,位置:急性髓性白血病患者CEBPA变异的小型回顾
Leukemia Research Reports Pub Date : 2023-01-01 DOI: 10.1016/j.lrr.2023.100386
Muhammad Salman Faisal , Pamela J. Sung
{"title":"Location, location, location: A mini-review of CEBPA variants in patients with acute myeloid leukemia","authors":"Muhammad Salman Faisal ,&nbsp;Pamela J. Sung","doi":"10.1016/j.lrr.2023.100386","DOIUrl":"https://doi.org/10.1016/j.lrr.2023.100386","url":null,"abstract":"<div><p><em>CEBPA</em> variants are frequently recurring in acute myeloid leukemia (AML). The prognostic significance of <em>CEBPA</em> mutations has recently undergone a major shift in the 5th edition of WHO classification of hematological neoplasms and ELN 2022 classification. Whereas prior iterations did not specify the type of <em>CEBPA</em> mutation, the updated schema specify that only mutations localized to the C-terminal basic zipper (bZIP) domain are considered prognostically favorable. This change is based primarily on three recently published large datasets evaluating the prognostic significance of mutation location in <em>CEBPA</em> mutant AML. Here, we review the evolution of the prognostic classification of <em>CEBPA</em> variants.</p></div>","PeriodicalId":38435,"journal":{"name":"Leukemia Research Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49857255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia 急性淋巴细胞白血病中l -天冬酰胺酶引起的急性胰腺炎的勘误表
Leukemia Research Reports Pub Date : 2023-01-01 DOI: 10.1016/j.lrr.2023.100375
Aziza Elouali , Soulaimane M'harzi , Karim Lahrache , Ayad Ghanam , Abdeladim Babakhouya , Maria Rkain , Noufissa Benajiba
{"title":"Corrigendum to Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia","authors":"Aziza Elouali ,&nbsp;Soulaimane M'harzi ,&nbsp;Karim Lahrache ,&nbsp;Ayad Ghanam ,&nbsp;Abdeladim Babakhouya ,&nbsp;Maria Rkain ,&nbsp;Noufissa Benajiba","doi":"10.1016/j.lrr.2023.100375","DOIUrl":"10.1016/j.lrr.2023.100375","url":null,"abstract":"","PeriodicalId":38435,"journal":{"name":"Leukemia Research Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213048923000158/pdfft?md5=b989c45c276e4f14d8d1157aaca34307&pid=1-s2.0-S2213048923000158-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46058135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder 新发作的细胞减少并不总是表明同种异体造血干细胞移植后复发的AML,这是一种非破坏性移植后淋巴细胞增生性疾病
Leukemia Research Reports Pub Date : 2023-01-01 DOI: 10.1016/j.lrr.2023.100369
Süreyya Yiğit Kaya , Abdullah Emre Askin , Sebnem Bektas , Aslı Çakır , Ömür Gökmen Sevindik
{"title":"Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder","authors":"Süreyya Yiğit Kaya ,&nbsp;Abdullah Emre Askin ,&nbsp;Sebnem Bektas ,&nbsp;Aslı Çakır ,&nbsp;Ömür Gökmen Sevindik","doi":"10.1016/j.lrr.2023.100369","DOIUrl":"10.1016/j.lrr.2023.100369","url":null,"abstract":"<div><p>Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains an effective option for the treatment of intermediate and high-risk Acute myeloid leukemia (AML). Post-transplant lymphoproliferative disorder (PTLD) is related to the intensity of post-transplant immunosuppression. Although Epstein-Barr virus (EBV) seropositivity and reactivation can be a major risk factor for PTLD. A few PTLDs could be EBV negative. There are a very limited number of PTLD cases following HSCT in patients with AML. We present a differential diagnosis of cytopenias after allo-HSCT. This is the first report of an AML patient developing bone marrow EBV-negative PTLD relatively late in their post-transplant course.</p></div>","PeriodicalId":38435,"journal":{"name":"Leukemia Research Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6f/b3/main.PMC10195982.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9503223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aggressive chronic lymphocytic leukemia masked by extensive marrow fibrosis 侵袭性慢性淋巴细胞白血病被广泛的骨髓纤维化所掩盖
Leukemia Research Reports Pub Date : 2023-01-01 DOI: 10.1016/j.lrr.2023.100390
Hareem Farooq , Ke Li , Talha Badar
{"title":"Aggressive chronic lymphocytic leukemia masked by extensive marrow fibrosis","authors":"Hareem Farooq ,&nbsp;Ke Li ,&nbsp;Talha Badar","doi":"10.1016/j.lrr.2023.100390","DOIUrl":"10.1016/j.lrr.2023.100390","url":null,"abstract":"<div><p>Chronic lymphocytic leukemia (CLL) is one of the most common B-cell leukemias, occurring because of abnormal proliferation of non-functional B-lymphocytes. Progressive disease is commonly complicated by anemia, thrombocytopenia, infections as well as secondary malignancies. Bone marrow fibrosis is infrequently co-occurred along with CLL. Although multiple explanations have been proposed for this association, the etiology remains unclear in most cases. Bone marrow fibrosis occurring as a complication of CLL itself, however, is a rare entity. We present an uncommon case of a patient initially diagnosed with primary myelofibrosis but later revealed to have aggressive CLL leading to bone marrow fibrosis upon re-evaluation. Treatment for CLL resolved the bone marrow fibrosis completely, confirming our suspicion of fibrosis being secondary to CLL. This sheds light on the importance of understanding the etiology of bone marrow fibrosis in patients with CLL owing to its therapeutic implications. The utility of bone marrow biopsy in not only helping understand the etiology of the fibrosis but also providing prognostic information merits reconsideration of performing it in all cases of CLL.</p></div>","PeriodicalId":38435,"journal":{"name":"Leukemia Research Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/56/main.PMC10480308.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10559774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Membranous nephropathy in chronic lymphocytic leukemia responsive to ibrutinib: A case report 慢性淋巴细胞白血病膜性肾病对伊鲁替尼反应:1例报告
Leukemia Research Reports Pub Date : 2023-01-01 DOI: 10.1016/j.lrr.2023.100377
Anna-Eve Turcotte , William F. Glass , Jamie S. Lin , Jan A. Burger
{"title":"Membranous nephropathy in chronic lymphocytic leukemia responsive to ibrutinib: A case report","authors":"Anna-Eve Turcotte ,&nbsp;William F. Glass ,&nbsp;Jamie S. Lin ,&nbsp;Jan A. Burger","doi":"10.1016/j.lrr.2023.100377","DOIUrl":"10.1016/j.lrr.2023.100377","url":null,"abstract":"<div><p>Membranous nephropathy (MN) is an uncommon renal presentation in patients with chronic lymphocytic leukemia (CLL), and as such, there is no standard therapy for these patients. A few cases of MN in CLL have been described with varying success in MN treatment involving alkylating agents and fludarabine. Here we report the first case of MN in a patient with CLL treated with ibrutinib with complete renal response. This presentation underlines the importance of recognizing rare glomerular diseases that may occur with CLL and offers a new therapeutic avenue to the treatment of CLL-associated MN.</p></div>","PeriodicalId":38435,"journal":{"name":"Leukemia Research Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e9/df/main.PMC10338352.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9881479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of aCML associated with CNS involvement and with aggressive clinical course 罕见的aCML伴中枢神经系统受累及侵袭性临床病程
Leukemia Research Reports Pub Date : 2023-01-01 DOI: 10.1016/j.lrr.2023.100361
Dorela Lame, Michelangelo Pianelli, Erika Morsia, Alberto Carturan, Gaia Goteri, Stefania Mancini, Attilio Olivieri, Antonella Poloni
{"title":"A rare case of aCML associated with CNS involvement and with aggressive clinical course","authors":"Dorela Lame,&nbsp;Michelangelo Pianelli,&nbsp;Erika Morsia,&nbsp;Alberto Carturan,&nbsp;Gaia Goteri,&nbsp;Stefania Mancini,&nbsp;Attilio Olivieri,&nbsp;Antonella Poloni","doi":"10.1016/j.lrr.2023.100361","DOIUrl":"10.1016/j.lrr.2023.100361","url":null,"abstract":"<div><p>The presence of neutrophilic leukocytosis may underlie a wide variety of diseases. Some rare causes of neutrophilia might be chronic neutrophilic leukemia (CNL) and myelodysplastic/myeloproliferative neoplasm with neutrophilia (MDS with neutrophilia). Here we report a case of a 78-year-old woman who came to our ER due to severe leukocytosis and anemia on a routine check-up. The patient was asymptomatic and the last exams available showed a mild leukopenia and thrombocytopenia. The abdominal echography showed mild splenomegaly The patient underwent bone marrow (BM) examinations. One week later, the patient presented mental deterioration. The patient underwent a cranial CT and RMN that showed multiple lesions of 11 mm in the brain parenchyma, cerebellum and encephalic trunk. Another week later, the clinical presentations worsened: she was in a comatous state and feverish 40 °C unresponsive to steroid therapy. Autopsy showed a leukemic and hemorrhage infiltration in multiple organs and in the BM a cellularity of 100% represented by myeloid elements with a slowdown maturation with blasts 5%. According to WHO 2016 this case can be reported as an aCML, an MDS/MPN overlap syndrome that is difficult to differentiate from a CNL.</p></div>","PeriodicalId":38435,"journal":{"name":"Leukemia Research Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c8/32/main.PMC9867965.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9190559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A case series of therapy-related leukemias: A deadly ricochet 一系列与治疗相关的白血病病例:致命的反弹
Leukemia Research Reports Pub Date : 2023-01-01 DOI: 10.1016/j.lrr.2023.100382
Ronit Juthani , Ashish Ranjan Singh , Debdatta Basu
{"title":"A case series of therapy-related leukemias: A deadly ricochet","authors":"Ronit Juthani ,&nbsp;Ashish Ranjan Singh ,&nbsp;Debdatta Basu","doi":"10.1016/j.lrr.2023.100382","DOIUrl":"10.1016/j.lrr.2023.100382","url":null,"abstract":"<div><p>Therapy-related leukemias(t-leukemia) are late complications arising from chemotherapy and radiotherapy. t-leukemia have a poor prognosis and are more difficult to treat compared to de novo leukemias. The authors present three cases of t-leukemia seen in our hospital in a three year period and discuss new updates concerning the treatment of t-leukemia.</p></div>","PeriodicalId":38435,"journal":{"name":"Leukemia Research Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430146/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10403491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide 同种异体干细胞移植治疗多发性骨髓瘤和骨髓纤维化,分剂量布磺胺、氟达拉滨和环磷酰胺
Leukemia Research Reports Pub Date : 2023-01-01 DOI: 10.1016/j.lrr.2023.100388
Andrew D. Trunk, Sagar S. Patel, Josef T. Prchal, Douglas W. Sborov, Axel R. Zander, Catherine J. Lee
{"title":"Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide","authors":"Andrew D. Trunk,&nbsp;Sagar S. Patel,&nbsp;Josef T. Prchal,&nbsp;Douglas W. Sborov,&nbsp;Axel R. Zander,&nbsp;Catherine J. Lee","doi":"10.1016/j.lrr.2023.100388","DOIUrl":"10.1016/j.lrr.2023.100388","url":null,"abstract":"<div><p>Allogeneic stem cell transplant can have high morbidity and mortality in patients with myelofibrosis (MF) and multiple myeloma (MM). This phase 2 study used a novel myeloablative regimen of split-dose busulfan, fludarabine, and then post-transplant cyclophosphamide. Four patients with MF and 2 with MM were enrolled. At 1 year, non-relapse mortality was 33.3%, and overall survival was 50%. Incidence of acute and chronic GVHD was 33.3% and 16.7%, respectively. Those surviving beyond 1 year (MF = 1, MM = 2) had durable remissions with a median follow-up of 42 months. This small study demonstrates relative safety &amp; favorable key outcomes using this novel approach.</p></div>","PeriodicalId":38435,"journal":{"name":"Leukemia Research Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/71/d5/main.PMC10493243.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10239728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contribution of rare and common coding variants to haematological malignancies in the UK biobank 在英国生物库中,罕见和常见的编码变异对血液系统恶性肿瘤的贡献
Leukemia Research Reports Pub Date : 2023-01-01 DOI: 10.1016/j.lrr.2023.100362
Bengt Zöller , Eric Manderstedt , Christina Lind-Halldén , Christer Halldén
{"title":"Contribution of rare and common coding variants to haematological malignancies in the UK biobank","authors":"Bengt Zöller ,&nbsp;Eric Manderstedt ,&nbsp;Christina Lind-Halldén ,&nbsp;Christer Halldén","doi":"10.1016/j.lrr.2023.100362","DOIUrl":"10.1016/j.lrr.2023.100362","url":null,"abstract":"","PeriodicalId":38435,"journal":{"name":"Leukemia Research Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/70/main.PMC9852684.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10577950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信